<DOC>
	<DOCNO>NCT01968733</DOCNO>
	<brief_summary>This study evaluate safety efficacy experimental antibiotic , solithromycin , treatment adult patient community-acquired pneumonia .</brief_summary>
	<brief_title>Efficacy Safety Study Intravenous Oral Solithromycin ( CEM-101 ) Compared Intravenous Oral Moxifloxacin Treatment Patients With Community-Acquired Bacterial Pneumonia</brief_title>
	<detailed_description>Community-acquired bacterial pneumonia ( CABP ) acute infection pulmonary parenchyma symptom fever hypothermia , chill , rigor , chest pain , and/or dyspnea . The widespread emergence antibiotic resistant pathogen , include macrolide-resistant Streptococcus pneumoniae , result need new effective antibiotic activity CABP pathogens . Solithromycin fourth generation macrolide antibiotic excellent activity resistant S. pneumoniae key typical atypical bacterial respiratory pathogen . A complete Phase 2 study show comparable efficacy levofloxacin adult CABP .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Male female patient â‰¥ 18 year age An acute onset least 3 follow sign symptom ( new worsen ) : 1 . Cough 2 . Production purulent sputum 3 . Shortness breath ( dyspnea ) 4 . Chest pain due pneumonia At least 1 follow : 1 . Fever 2 . Hypothermia 3 . Presence pulmonary rale and/or evidence pulmonary consolidation PORT Risk Class II , III , IV Presence lobar , multilobar , patchy parenchymal infiltrate ( ) consistent acute bacterial pneumonia pulmonary imaging study Not receive systemic antibiotic prior 7 day Ventilatorassociated pneumonia Known anatomical pathological bronchial obstruction history bronchiectasis document severe chronic obstructive pulmonary disease Hospitalization within 90 day residence longterm care facility within 30 day prior onset symptom Fungal pneumonia Pneumocystis jiroveci pneumonia Aspiration pneumonia Other noninfectious cause pulmonary infiltrates Primary metastatic lung cancer Cystic fibrosis Active suspect tuberculosis HIV myasthenia gravis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pneumonia</keyword>
	<keyword>CABP</keyword>
	<keyword>CAP</keyword>
	<keyword>Macrolide</keyword>
</DOC>